J&J Slammed With $482M Verdict In Stent Patent Suit

Law360, New York (January 28, 2011, 6:41 PM EST) -- A federal jury hit Johnson & Johnson with a $482 million verdict on Friday, finding that the company's popular Cypher coronary stent infringes a patent held by a New Jersey radiologist.

The jury in the U.S. District Court for the Eastern District of Texas took just two hours to return the verdict in favor of Dr. Bruce N. Saffran, who had prevailed in a separate suit over the same patent in 2008, that time winning a $432 million decision against Boston Scientific Corp.

“We are gratified...
To view the full article, register now.